QCM
RPRX icon

Quantinno Capital Management’s Royalty Pharma RPRX Stock Holding History

Quantinno Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4M Buy
470,482
+87,911
+23% +$4.58M 0.03% 614
2026
Q1 		$18.4M Buy
382,571
+41,417
+12% +$1.81M 0.03% 653
2025
Q4 		$13.2M Sell
341,154
-53,962
-14% -$2.06M 0.03% 684
2025
Q3 		$13.9M Buy
395,116
+186,232
+89% +$6.74M 0.04% 527
2025
Q2 		$7.53M Buy
208,884
+88,096
+73% +$2.92M 0.03% 650
2025
Q1 		$3.76M Buy
120,788
+47,408
+65% +$1.5M 0.02% 770
2024
Q4 		$1.87M Buy
73,380
+16,945
+30% +$449K 0.02% 873
2024
Q3 		$1.6M Buy
56,435
+16,982
+43% +$470K 0.02% 810
2024
Q2 		$1.04M Sell
39,453
-6,001
-13% -$166K 0.02% 791
2024
Q1 		$1.38M Buy
45,454
+15,672
+53% +$462K 0.03% 648
2023
Q4 		$837K Buy
29,782
+21,667
+267% +$595K 0.03% 668
2023
Q3 		$220K Buy
+8,115
New +$241K 0.01% 957
2023
Q2 		– Sell
-7,401
Closed -$267K – 944
2023
Q1 		$267K Buy
+7,401
New +$274K 0.02% 748

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's RPRX Position: Q2 2026 in Review

Quantinno Capital Management increased its Royalty Pharma (RPRX) stake by 23% in Q2 2026, buying an estimated $4.58M and bringing the position to 470,482 shares worth $26.4M. The position accounts for 0.03% of the portfolio, ranked #614.

Quantinno Capital Management first reported a position in RPRX in Q1 2023 and has held it in 13 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Quantinno Capital Management held 470,482 shares of Royalty Pharma worth $26.4M as of Q2 2026.
  • Quantinno Capital Management bought 87,911 Royalty Pharma shares in Q2 2026, an estimated $4.58M.
  • Royalty Pharma made up 0.03% of Quantinno Capital Management's portfolio in Q2 2026, its #614 holding.
  • Quantinno Capital Management first reported a position in Royalty Pharma in Q1 2023 and has held it in 13 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.